You are here

EMA

Johnson & Johnson's COVID-19 vaccine under scrutiny at EMA after 4 'serious cases' of unusual blood clots

Fierce Pharma

Fri, 04/9/21 - 10:43 am

AbbVie presents applications to FDA and EMA for approval of SKYRIZI in psoriatic arthritis

Pharmaceutical Business Review

Thu, 04/8/21 - 10:22 am

psoriatic arthritis

AstraZeneca COVID-19 vaccine linked to rare blood clots, EMA official says, but benefits still outweigh risks

Fierce Pharma

Tue, 04/6/21 - 10:43 am

EMA approves new storage conditions for Pfizer/BioNTech COVID-19 vaccine

Biopharma Reporter

Tue, 03/30/21 - 11:53 am

EMA judges AstraZeneca vaccine safe after blood clot investigation

RAPS.org

Thu, 03/18/21 - 08:42 pm

EMA begins safety review of bluebird gene therapy following AML case in related therapy

Endpoints

Fri, 03/12/21 - 10:32 am

EMA validates Pfizer and OPKO’s somatrogon marketing application for review

Pharmaceutical Business Review

Mon, 03/1/21 - 10:29 am

growth hormone deficiency

Janssen's COVID vaccine application submitted to EMA

RAPS.org

Tue, 02/16/21 - 11:38 pm

CureVac's COVID vaccine enters EMA's rolling review

RAPS.org

Sat, 02/13/21 - 11:04 pm

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA

Drug Patent Watch

Wed, 02/3/21 - 10:52 pm

Janssen flags accelerated approval milestone in Europe for CAR-T therapy

Biopharma Reporter

Mon, 02/1/21 - 11:04 pm

Cyberattack: EMA says leaked documents ‘manipulated’

RAPS.org

Sat, 01/16/21 - 11:40 pm

Hackers steal Pfizer, BioNTech data in EMA breach as cybersecurity attacks heat up

Endpoints

Thu, 12/10/20 - 11:11 am

Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submission

Pharmaforum

Fri, 11/13/20 - 12:11 pm

Multiple Myeloma

Why DBV Technologies Stock Is Soaring Today

Motley Fool

Mon, 11/2/20 - 11:04 pm

DBV Technologies

Study: Few new drugs have high therapeutic value

RAPS.org

Mon, 10/12/20 - 08:17 pm

British Medical Journal

therapeutic value

Thinking the unthinkable on Covid vaccine approvals

EP Vantage

Wed, 10/7/20 - 11:04 am

European Medicines Agency reviewing reports of kidney injury in patients taking Gilead's remdesivir

Beckers Hospital Review

Mon, 10/5/20 - 11:55 pm

Gilead Sciences

Takeda takes a $200M hit after Novartis is forced to yank its marketing application for Xiidra

Endpoints

Mon, 06/29/20 - 10:26 am

dry eye disease

Vertex : CHMP Grants Positive Opinion For KAFTRIO - KALYDECO In People Ages 12 And Older With CF

Business Insider

Fri, 06/26/20 - 07:47 pm

Vertex Pharmaceuticals

cystic fibrosis

Pages